VAERS Explorer
Back to explore

Report #2865548

Received Oct 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
NY
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNK—IM

Symptoms (1)

Lung disorder

Symptom narrative

lung conditions; This spontaneous case was reported by a consumer and describes the occurrence of LUNG DISORDER (lung conditions) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced LUNG DISORDER (lung conditions) (seriousness criterion medically significant). At the time of the report, LUNG DISORDER (lung conditions) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) was unknown. No concomitant medications provided by the reporter. It was reported that the patient received Moderna vaccine since 2021 but now they cannot find it in their area. It was reported that the patient has a serious lung condition, and he must avoid all the respiratory infections. It was also reported that if patient did not find Moderna vaccine, then he can use Pfizer vaccination. No treatment medications provided by the reporter. This case was linked to MOD-2025-790011 (Patient Link).; Reporter's Comments: Unspecified lung disorder was assessed as not related to suspected vaccine. Based on available, very limited information this condition seems to be part of medical history, not an adverse reaction. Additionally, patient is taking Moderna COVID-19 Vaccine since 2021 to prevent infections as he has lung disorder, which suggest presence of lung disorder before the first vaccination. The benefit-risk relationship of the product is not affected by this report.